Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Rectal MRI Synoptic Reporting Conjoint recommendations from the NZ branch of the RANZCR and the National Bowel Cancer Working Group (NBCWG) General Background Synoptic reporting has been gaining increasing traction over the last few years - especially for oncology staging and screening studies. This is secondary to both internal pressures from within radiology, as well as external pressures from other clinicians and government initiatives. The government established the National Tumour Standards as part of the Faster Cancer Treatment programme in 2013 - ten standards in all, covering the majority of cancers. Almost all of these national tumor standards mandate that patient treatment plans should be discussed at an MDT meeting; and within these meetings the staging of the cancer often determines the course of treatment (eg. straight to surgery vs. adjuvant chemotherapy vs. palliative care). Radiological staging is now the mainstay of overall staging. Of note, these tumour standards do mandate synoptic reporting of pathology, and radiology might therefore not be far behind. Within the MDT there is emphasis on standardized staging of cancers based on the American Joint Committee on Cancer (AJCC) manual (now up to edition 7). Often the lead radiologist at the MDT will be reviewing complex cases they haven't formally reported themselves, as well as cases from outside their own DHB - accordingly standardized reports facilitate a more straight forward review process, as well as minimizing and clarifying discordant results. Outside of the MDT setting standardized reports are easier for referring surgeons and physicians to review and extract the necessary staging information, and plan any proposed surgery. Overall, one can conclude from all this that synoptic reporting for oncology cases is preferred by clinicians, may be mandated by the government (via the FCT programme) in the future, and most importantly makes the job of an MDT lead radiologist easier. Rectal MRI background For bowel cancer there are 23 standards set up by the NBCWG under the auspices of the Ministry of Health - of these, standard #10 mandates rectal MRI for all non-metastatic rectal cancer patients. Currently there is no timeframe stipulation on this (although it is clearly integral to the other time focused standards), nor is there any stipulation for synoptic reporting. The NBCWG is composed about approximately 20 experts in the field of bowel cancer including surgeons, oncologists, radiation oncologists, radiologists, pathologists, support staff and MOH representatives. The standards and issues around them are routinely reviewed; and at the most recent meeting of the NBCWG in March 2015, several of the clinical oncologists, radiation oncologists, and surgeons independently expressed frustration with the variability in both quality and reporting style of rectal MRI. This was of great concern given how crucial the rectal MRI report is for staging and determining treatment pathways. The consensus view of the clinicians was that standardization of reports was desirable. From the clinicians point of view there were three main areas where standardization would be beneficial: MDTs, data collection, and surgical planning. From the radiologists perspective it is hard to argue against the concerns raised; and in fact at many NZ hospitals and radiology practices, synoptic reporting is already standard. This is not uniform however by any measure, and the template of synoptic reports used do still vary somewhat. The NBCWG were therefore of the opinion that distribution of a communique to all NZ radiologists, under the joint banner of the group and the RANZCR (NZ branch), would best bring this issue to the attention of radiologists in NZ; and hopefully encourage our members to adopt synoptic reporting of rectal MRI within their hospitals and radiology clinics. Minimum requirements for a Synoptic MRI Rectum report Whilst a synoptic report of a rectal MRI might vary in format and depth, there is a fairly well established list of key findings that should be included in any report, to enable accurate staging and allow clinicians to choose the best treatment plan. These fall under the broad TNM headings, but with additional findings that have a major impact on both planned surgery and the need for neo-adjuvant therapy. This list covers the essential findings for complete staging and treatment planning, but there are a number of additional features included in templates used at various hospitals whether these are useful or not is best established locally. Two examples are included in the appendix (and there are many more available) from both Auckland DHB and the Ontario health service. The well researched background explanatory pdf from Ontario is also included, or can be accessed via: https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=133269 TUMOUR Location - low/mid/upper and distance from anal verge Size - length and degree of circumferential involvement T stage - T2, T2/3, T3, or T4 EMVI - is there any extra mural venous invasion? MRF - distance from tumour/EMVI to closest mesorectal fascia in any plane Peritoneal reflection - does the tumour extend above the anterior reflection - if yes, is there any T3 disease above the reflection NODES Peri-rectal nodes? - if yes, how many at least moderately suspicious for involvement - distance from MRF to closest involved node Other regional nodes? - if yes, how many N stage - based on total number of involved regional lymph nodes (N0, N1, or N2) METASTASES Metastatic non-regional nodes? - external or common iliac nodes considered metastatic Other metastatic sites? - bone and peritoneum M stage - noting that staging CT scan will be required to fully stage for metastatic disease Conclusion: The issue of whether to adopt synoptic reporting is a complex one, and will undoubtedly attract much debate for some time yet. However the use of synoptic reporting for rectal MRI is clearly advantageous to the patient, the clinical team, and the radiologists involved. The National Bowel Cancer Working Group would like to bring this to the attention of all NZ radiologists, with the support of the RANZCR, to recommend the use of standardized synoptic reporting for rectal MRI.